Coherus Oncology, Inc. (CHRS) vs OptimizeRx Corp. (OPRX)
A side-by-side comparison of Coherus Oncology, Inc. and OptimizeRx Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CHRS
Coherus Oncology, Inc.
$1.05HealthcareDelayed quote: Oct 6, 2026, 12:24 PM EDT
OPRX
OptimizeRx Corp.
$8.84HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT
Total return — CHRS vs OPRX
growth of $100 · dividends reinvested · last 10yCHRS -95.6% (-26.8%/yr)OPRX +169.1% (+10.4%/yr)OPRX compounded faster over this window
Log scale — wide-divergence pair
CHRS OPRX
CHRS vs OPRX: by the numbers
- •OPRX is the larger company ($166M vs $162M market cap).
- •OPRX is profitable (4.66% net margin) while CHRS runs a net loss (-257.10%).
- •OPRX grew revenue faster over the past five years (13.75% vs -33.60% CAGR).
Metrics side by side
Valuation
| Metric | CHRS | OPRX |
|---|---|---|
| P/E ratio | N/A | 37.82 |
| Forward P/E | N/A | 9.85 |
| P/S ratio | 3.18 | 1.68 |
| P/B ratio | 2.67 | 1.26 |
| EV / EBITDA | N/A | 10.44 |
| FCF yield | N/A | 11.07% |
Profitability
| Metric | CHRS | OPRX |
|---|---|---|
| Gross margin | 63.55% | 63.30% |
| Operating margin | -425.72% | 11.45% |
| Net margin | -257.10% | 4.66% |
| ROE | -215.26% | 3.51% |
| ROIC | -135.38% | 4.92% |
Growth (annualized)
| Metric | CHRS | OPRX |
|---|---|---|
| Revenue CAGR (5Y) | -33.60% | 13.75% |
| Total return CAGR (5Y) | -41.38% | -36.23% |
Frequently asked
- Which has grown faster, CHRS or OPRX?
- Over the past five years, OPRX grew revenue faster — CHRS at a -33.60% CAGR versus OPRX at 13.75%.
- Is CHRS or OPRX more profitable?
- OPRX runs the higher net margin — CHRS at -257.10% versus OPRX at 4.66%.
- How have CHRS and OPRX total returns compared?
- Over the past 10 years, CHRS delivered -26.92% and OPRX delivered 10.21% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
OptimizeRx P/E ratioCoherus Oncology ROEOptimizeRx ROECoherus Oncology operating marginOptimizeRx operating marginCoherus Oncology revenue growthOptimizeRx revenue growthCoherus Oncology free cash flowOptimizeRx free cash flow
Coherus Oncology & OptimizeRx appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.